thirty-one unselected patients with untreated acute non lymphoblastic leukemia ( anll ) ranging in age from 15 to 76 years received two courses of a new high-dose induction regimen consisting of idarubicin , etoposide and cytarabine .
C0023467
acute non lymphoblastic leukemia
C0015133
etoposide